Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coherus Oncology (CHRS) Change in Accured Expenses (2016 - 2025)

Coherus Oncology (CHRS) has disclosed Change in Accured Expenses for 13 consecutive years, with $9.9 million as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 265.32% to $9.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.8 million through Dec 2025, up 93.38% year-over-year, with the annual reading at -$3.8 million for FY2025, 93.38% up from the prior year.
  • Change in Accured Expenses hit $9.9 million in Q4 2025 for Coherus Oncology, up from -$6.3 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $16.9 million in Q1 2021 to a low of -$46.6 million in Q2 2024.
  • Historically, Change in Accured Expenses has averaged -$1.6 million across 5 years, with a median of $817500.0 in 2023.
  • Biggest five-year swings in Change in Accured Expenses: skyrocketed 926.55% in 2021 and later crashed 5313.87% in 2024.
  • Year by year, Change in Accured Expenses stood at $1.4 million in 2021, then dropped by 13.3% to $1.2 million in 2022, then skyrocketed by 202.87% to $3.7 million in 2023, then crashed by 261.73% to -$6.0 million in 2024, then soared by 265.32% to $9.9 million in 2025.
  • Business Quant data shows Change in Accured Expenses for CHRS at $9.9 million in Q4 2025, -$6.3 million in Q3 2025, and $996000.0 in Q2 2025.